DAVID NAROTSKY
Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease FAIRFIELD, CT NPI 1831469832
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease CT Amgen Inc. All categories
General Payments — all program years on this page
$771.34
- Category: General Payments
- Program years: PY2018–2019
- Record count: 16
- As of (CMS publication): 2026-01-23
Latest program year (PY2019): $524.53 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2019) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $524.53 | 9 |
By paying entity
Latest program year (PY2019) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $162.55 | 3 |
| Acerta Pharma LLC | $128.57 | 1 |
| Janssen Pharmaceuticals, Inc | $125.00 | 1 |
| Braemar Manufacturing, LLC | $55.26 | 1 |
| PFIZER INC. | $28.57 | 2 |
| E.R. Squibb & Sons, L.L.C. | $24.58 | 1 |
By program year
Records — PY2019 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 651375035 | E.R. Squibb & Sons, L.L.C. | $24.58 | 02/27/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 659081701 | Janssen Pharmaceuticals, Inc | $125.00 | 04/11/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 662285899 | Amgen Inc. | $117.91 | 01/17/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 663226769 | Amgen Inc. | $20.77 | 01/09/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 672338557 | PFIZER INC. | $14.65 | 01/16/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 672396365 | PFIZER INC. | $13.92 | 02/08/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 685505603 | AstraZeneca Pharmaceuticals LP | $128.57 | 04/16/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 701638901 | Braemar Manufacturing, LLC | $55.26 | 04/23/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 731296263 | Amgen Inc. | $23.87 | 05/13/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.